The prognostic value of chemotherapy or endocrine therapy choice according to circulating tumor cell count in HR + HER2 - metastatic breast cancer: a retrospective study.

Bin Shao,Huiping Li,Jiayang Zhang,Xiaoran Liu,Guohong Song,Hanfang Jiang,Ying Yan,Huan Wang,Jing Wang,Lijun Di

Annals of translational medicine（2022）

引用 0|浏览18

暂无评分

摘要

The present study showed that CTC count determined by the Pep@MNP system confirmed the prognostic value in the HRHER2 MBC patients. And it might be helpful in choosing a 1st-line treatment of CT or ET for HRHER2 MBC patients.

查看译文

关键词

Metastatic breast cancer (MBC),chemotherapy (CT),circulating tumor cells (CTCs),endocrine therapy (ET)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要